ING Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.9M Buy
+58,673
New +$24.8M 0.11% 145
2025
Q4
Sell
-2,405
Closed -$1.03M 591
2025
Q3
$1.03M Buy
+2,405
New +$932K 0.01% 438
2025
Q2
Sell
-27,864
Closed -$9.63M 525
2025
Q1
$9.63M Sell
27,864
-19,080
-41% -$6.14M 0.07% 169
2024
Q4
$14.1M Sell
46,944
-2,257
-5% -$789K 0.09% 155
2024
Q3
$20M Buy
49,201
+35,807
+267% +$13.1M 0.12% 132
2024
Q2
$4.3M Sell
13,394
-48,747
-78% -$15.8M 0.03% 354
2024
Q1
$20.7M Buy
62,141
+25
+0% +$7.64K 0.14% 130
2023
Q4
$16.8M Buy
62,116
+5,048
+9% +$1.25M 0.14% 155
2023
Q3
$14M Buy
57,068
+27,597
+94% +$7.55M 0.12% 153
2023
Q2
$8.94M Sell
29,471
-6,560
-18% -$1.82M 0.07% 200
2023
Q1
$9.5M Buy
+36,031
New +$9.15M 0.09% 176
2022
Q4
Sell
-5,026
Closed -$924K 539
2022
Q3
$924K Sell
5,026
-37,789
-88% -$7.53M 0.02% 358
2022
Q2
$7.2M Buy
42,815
+4,819
+13% +$1.04M 0.08% 191
2022
Q1
$9.52M Buy
37,996
+6,738
+22% +$1.69M 0.1% 163
2021
Q4
$8.03M Buy
31,258
+10,562
+51% +$2.58M 0.07% 209
2021
Q3
$5.02M Sell
20,696
-889
-4% -$217K 0.06% 194
2021
Q2
$4.46M Buy
21,585
+4,030
+23% +$821K 0.07% 174
2021
Q1
$3.31M Buy
17,555
+49
+0.3% +$8.64K 0.07% 173
2020
Q4
$2.88M Buy
17,506
+11,671
+200% +$1.71M 0.06% 188
2020
Q3
$728K Buy
5,835
+3,608
+162% +$447K 0.03% 230
2020
Q2
$216K Sell
2,227
-34,614
-94% -$3.6M 0.01% 264
2020
Q1
$3.31M Buy
36,841
+18,694
+103% +$2.42M 0.14% 93
2019
Q4
$2.68M Buy
18,147
+1,548
+9% +$208K 0.08% 172
2019
Q3
$2M Sell
16,599
-23,335
-58% -$3.02M 0.05% 224
2019
Q2
$5.4M Buy
39,934
+159
+0.4% +$20.1K 0.09% 146
2019
Q1
$5.19M Buy
39,775
+8,556
+27% +$1.15M 0.11% 124
2018
Q4
$3.88M Sell
31,219
-1,224
-4% -$164K 0.08% 154
2018
Q3
$4.51M Buy
32,443
+2,521
+8% +$314K 0.08% 170
2018
Q2
$3.07M Buy
29,922
+1,321
+5% +$134K 0.06% 181
2018
Q1
$2.77M Buy
+28,601
New +$2.78M 0.05% 185
2017
Q4
Sell
-31,596
Closed -$2.52M 805
2017
Q3
$2.52M Buy
31,596
+9,168
+41% +$737K 0.05% 202
2017
Q2
$1.96M Sell
22,428
-91
-0.4% -$7.7K 0.04% 221
2017
Q1
$2M Sell
22,519
-41,814
-65% -$3.49M 0.04% 253
2016
Q4
$4.75M Buy
+64,333
New +$4.82M 0.09% 147
2016
Q3
Sell
-50,358
Closed -$3.88M 585
2016
Q2
$3.88M Buy
50,358
+47,355
+1,577% +$3.74M 0.05% 152
2016
Q1
$234K Sell
3,003
-9,725
-76% -$679K ﹤0.01% 493
2015
Q4
$861K Sell
12,728
-929,965
-99% -$64.9M 0.01% 518
2015
Q3
$72.9M Sell
942,693
-365,091
-28% -$32.3M 0.5% 45
2015
Q2
$119M Buy
1,307,784
+1,296,164
+11,155% +$104M 0.64% 33
2015
Q1
$874K Buy
+11,620
New +$834K ﹤0.01% 612
2014
Q3
Sell
-253,000
Closed -$14.3M 649
2014
Q2
$14.3M Sell
253,000
-62,000
-20% -$3.27M 0.07% 225
2014
Q1
$16.5M Sell
315,000
-285,000
-48% -$14.2M 0.09% 219
2013
Q4
$28.6M Buy
+600,000
New +$27.7M 0.14% 158

Other funds holding HCA

ING Group's HCA Position: Q2 2026 in Review

ING Group opened a new position in HCA Healthcare (HCA) in Q2 2026: 58,673 shares worth $22.9M. The stake represents 0.11% of the portfolio and ranks #145 among its holdings. This is a return to the name: ING Group previously reported a position in HCA as recently as Q3 2025.

ING Group first reported a position in HCA in Q4 2013 and has held it in 43 quarters since. The position peaked at $119M in Q2 2015. 1,337 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • ING Group held 58,673 shares of HCA Healthcare worth $22.9M as of Q2 2026.
  • HCA Healthcare was a new ING Group position in Q2 2026.
  • HCA Healthcare made up 0.11% of ING Group's portfolio in Q2 2026, its #145 holding.
  • ING Group first reported a position in HCA Healthcare in Q4 2013 and has held it in 43 quarters since.
  • ING Group's HCA Healthcare position peaked at $119M in Q2 2015.
  • 1,337 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on ING Group's 13F filing for Q2 2026, filed 13 Aug 2026.